Your browser doesn't support javascript.
loading
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Landewé, Robert B M; Poddubnyy, Denis; Rahman, Proton; Van den Bosch, Filip E; Bolce, Rebecca; Liu Leage, Soyi; Lisse, Jeffrey R; Park, So Young; Gensler, Lianne.
Afiliação
  • Landewé RBM; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands landewe@rlandewe.nl.
  • Poddubnyy D; Rheumatology Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Rahman P; German Rheumatism Research Centre, Berlin, Germany.
  • Van den Bosch FE; Division of Rheumatology, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
  • Bolce R; Department of Internal Medicine and Pediatrics, Ghent University, Gent, Belgium.
  • Liu Leage S; VIB Center for Inflammation Research, Ghent, Belgium.
  • Lisse JR; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Park SY; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Gensler L; Eli Lilly and Company, Indianapolis, Indiana, USA.
Ann Rheum Dis ; 82(2): 212-216, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36100350
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2023 Tipo de documento: Article